Alzheimer's Disease
The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers
(By Arthur Allen for KFF Health News) The first drug purporting to slow the advance of Alzheimer’s disease is likely to cost the U.S. health care system billions annually even as it remains out of reach for many of the…
Will the new Alzheimer’s drug put pressure on Medicare premiums?
The FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the advance of Alzheimer’s disease. Although the last Alzheimer’s disease drug caused Medicare Part B premiums to rise an incredible 14.5…
Minimizing the Risk of Scams for People Living with Dementia
(Source -www.ssa.gov/blog) Financial crime against older Americans is a growing problem. People living with dementia are at an especially high risk of becoming victims of fraud and financial abuse. That’s why we’re grateful for Social Security’s unwavering commitment to combatting…